echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > The Lancet: After contracting the new crown, the risk of diabetes increases, even in patients with mild symptoms

    The Lancet: After contracting the new crown, the risk of diabetes increases, even in patients with mild symptoms

    • Last Update: 2022-04-27
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Written | Edited by Wang Cong | Typesetting by Wang Duoyu | Shui Chengwen research paper
    .

    The large-scale study of nearly 200,000 people showed that people with Covid-19 had an increased risk of diabetes a year later, even those with mild symptoms, compared with those without Covid-19
    .

    Ziyad Al-Aly, the paper's corresponding author and director of the St.
    Louis Health Care System at the Missouri Department of Veterans Affairs, said: "When the new crown pandemic subsides, we will have to face the "legacy" of the pandemic -- chronic diseases.
    And the healthcare system isn't ready for that right now
    .

    Increased risk Ziyad Al-Aly and his colleague Xie Yan reviewed the medical records of more than 180,000 people who survived for more than a month after contracting the new coronavirus
    .

    They compared those records with the medical records of two groups of more than 4 million people who were not infected with the new coronavirus
    .

    They have previously demonstrated through similar studies that infection with the new coronavirus increases the risk of kidney disease, heart failure and stroke
    .

    In the study, they found that a control group without Covid-19 had a diagnosis of diabetes at a rate of 35 per 1,000 a year later, compared with 48 per 1,000 among those who contracted Covid-19.
    Almost all cases are type 2 diabetes, which is caused by the body becoming resistant to insulin or not producing enough insulin
    .

    People infected with Covid-19 had a nearly 40 percent higher risk of developing diabetes a year later than those in a control group who didn't have Covid-19
    .

    The risk of developing diabetes increases with the severity of Covid-19, with people hospitalized or severely ill with Covid-19 having about three times the risk of diabetes compared to a control group without Covid-19
    .

    In addition, the study found that even those with mild post-COVID-19 disease and no risk factors for diabetes had an increased risk of developing diabetes
    .

    And those with a high BMI and obesity more than doubled the risk of diabetes after contracting COVID-19
    .

    Global Burden At present, the number of new crowns around the world is still increasing rapidly, and the cumulative number of confirmed cases has exceeded 480 million
    .

    Such a huge number of infected people means that the world will usher in a huge burden of diabetes
    .

    But other diabetes experts pointed out that the study was conducted on U.
    S.
    military veterans, mostly older white men, who are not inherently at low risk for diabetes
    .

    Young people are not at high risk of developing diabetes
    .

    An elusive cause Early in the pandemic, studies in young adults and children suggested that the virus could damage insulin-producing cells in the pancreas, triggering type 1 diabetes
    .

    However, follow-up studies have concluded that there is no evidence that the new crown will increase the risk of type 1 diabetes in young people and children
    .

    There are also studies refuting the idea that the new coronavirus can damage pancreatic cells
    .

    In addition, there is a question of whether the metabolic changes observed in the new crown patients will persist after a year
    .

    Therefore, more research is needed to elucidate the long-term trends of new-onset diabetes in people with COVID-19 and to find the reasons for this risk
    .

    Reference: https://#ref-CR1 https://doi.
    org/10.
    1016/S2213-8587(22)00044-4 Open for reprinting and welcome to forward to friends circle and wechat group 
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.